Please see the following RG links.

Article Liver injury in COVID-19: management and challenges

Article Risk of severe illness from COVID-19 in patients with metabo...

Article COVID-19 and Liver Dysfunction: Current Insights and Emergen...

Article Liver injury in COVID-19: The current evidence

Article Liver and Kidney Injuries in COVID-19 and Their Effects on D...

Preprint Clinical Features of COVID-19 Related Liver Damage

Article Potential implications of COVID‐19 in non‐alcoholic fatty li...

Article Implication of non-alcoholic fatty liver diseases (NAFLD) in...

Liver injury was common in the patients infected by the other two highly pathogenic coronavirus—SARS-CoV and the Middle East respiratory syndrome coronavirus—and associated with the severity of diseases. In patients with COVID-19, several studies have reported the incidence of liver injury, indicating that 2% to 11% of patients with COVID-19 had liver comorbidities and 16% to 53% cases reported abnormal levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) .

Liver injury in patients with COVID-19 might be due to viral infection in liver cells or due to other causes such as drug-induced liver injury and systemic inflammation induced by cytokine storm or pneumonia-associated hypoxia

1. Xu L, Liu J, Lu M, Yang D, Zheng X. Liver injury during highly pathogenic human coronavirus infections. Liver Int 2020. In press.

• Cited Here

2. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020;5:428–30.

• Cited Here

Patients with chronic liver disease do not seem to be at greater risk of acquiring the infection than other individuals in the general population. People who are infected with SARS-CoV-2 appear to relatively spare the liver or have only a modest effect

(Mild to moderate elevation of AST and to a lesser extent ALT) with the exception of liver failure in patients with very severe COVID-19 infection leading to multi-visceral deficiencies and of patients with decompensated cirrhosis of the liver.

Ref: Article COVID-19 and the liver-related deaths to come

please have a look at the following link:

Article The impact of the COVID‐19 outbreak on Liver Transplantation...

Please look into the attached document:

agree with Dr. Gamal Abdul Hamid and Dr. Harasit Kumar Paul ,,, it can target rest of organs too.